CDH1 and ductal breast carcinoma in situ: Of these, eight cases showed aberrant E-cadherin protein expression in the Abr component; one tumour (ML10) harboured E-cadherin positive ductal carcinoma in situ (DCIS); and one tumour (ML2) had positive E-cadherin protein expression (Figure 1, Table S1).